Literature DB >> 33617801

Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties.

Xumin Zhang1, Long Xie2, Jiaying Long3, Qingxuan Xie4, Yu Zheng5, Kai Liu6, Xiaofang Li7.   

Abstract

Salidroside has been identified as one of the most potent compounds isolated from various Rhodiola plants, which have been used for a long time as adaptogens in traditional Chinese medicine. However, due to the severe growing environment of herbal medicine and large-scale excavation, the content of natural salidroside is extremely small. Most of the previous studies focused on herbal medicine, and there were few reviews on the synthesis of its main active ingredient salidroside. This paper presents different synthetic routes of salidroside to resolve the contradiction between supply and demand and lays the foundation for new drug research and development. Furthermore, emerging evidence indicates that salidroside, a promising environmentally-adapted drug with low toxicity and few side effects, possesses a wide spectrum of pharmacological properties, including activities on the cardiovascular system and central nervous system, anti-hypoxia, anti-fatigue and anti-aging activities, anticancer activity, anti-inflammatory activity, antioxidant activity, antivirus and immune stimulation activities, antidiabetic activity, anti-osteoporotic activity, and so on. Although the former researches have summarized the pharmacological effects of salidroside, focusing on the central nervous system, diabetes, and cancer, the overall pharmacological aspects of it have not been analyzed. This review highlights biological characteristics and mechanisms of action from 2009 to now as well as toxicological and pharmacokinetic data of the analyzed compound reported so far, with a view to providing a reference for further development and utilization of salidroside.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Mechanisms; Pharmacokinetics; Pharmacology; Salidroside; Synthesis; Toxicology

Mesh:

Substances:

Year:  2021        PMID: 33617801     DOI: 10.1016/j.cbi.2020.109268

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  11 in total

1.  Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer's disease mice and glutamate-injured HT22 cells.

Authors:  Sixia Yang; Zeping Xie; Tingting Pei; Yi Zeng; Qiaowu Xiong; Hui Wei; Yong Wang; Weidong Cheng
Journal:  Chin Med       Date:  2022-07-04       Impact factor: 4.546

2.  Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α.

Authors:  Hui Gao; Kunming Tian; Yichong Meng; Xueping Liu; Yingfu Peng
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

3.  Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis.

Authors:  Yawen Cai; Yuhui Chai; Yu Fu; Yingdi Wang; Yiming Zhang; Xue Zhang; Lingpeng Zhu; Mingxing Miao; Tianhua Yan
Journal:  Front Aging Neurosci       Date:  2022-01-21       Impact factor: 5.750

4.  Insight into the Protective Effect of Salidroside against H2O2-Induced Injury in H9C2 Cells.

Authors:  Hui Gao; Xueping Liu; Kunming Tian; Yichong Meng; Cuicui Yu; Yingfu Peng
Journal:  Oxid Med Cell Longev       Date:  2021-11-30       Impact factor: 6.543

5.  Enzymatic Biosynthesis of Simple Phenolic Glycosides as Potential Anti-Melanogenic Antioxidants.

Authors:  Hogwuan Jung; JaeWook Oh; Younghae Kwon; Woongshin Kang; Minsuk Seo; Yurin Seol; Je Won Park
Journal:  Antioxidants (Basel)       Date:  2022-07-19

6.  Salidroside alleviates hepatic ischemia-reperfusion injury during liver transplant in rat through regulating TLR-4/NF-κB/NLRP3 inflammatory pathway.

Authors:  Yanyao Liu; Zilun Lei; Hao Chai; Quan Kang; Xiaoyan Qin
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

7.  Erythropoietin mediates re-programming of endotoxin-tolerant macrophages through PI3K/AKT signaling and protects mice against secondary infection.

Authors:  Xue Zhang; Dan He; Jialin Jia; Feihong Liang; Jie Mei; Wenhua Li; Tingting Liu; Zhiyu Wang; Yu Liu; Fengxue Zhang; Zhiren Zhang; Bangwei Luo
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

8.  Natural Phenylethanoid Supplementation Alleviates Metabolic Syndrome in Female Mice Induced by High-Fructose Diet.

Authors:  Xiujun Zhan; Mingshuai He; Jierong Pei; Wenjing Fan; Charity Ngina Mwangi; Peng Zhang; Xin Chai; Miaomiao Jiang
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

Review 9.  Therapeutics That Can Potentially Replicate or Augment the Anti-Aging Effects of Physical Exercise.

Authors:  Adriana De Sousa Lages; Valentim Lopes; João Horta; João Espregueira-Mendes; Renato Andrade; Alexandre Rebelo-Marques
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 10.  Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.

Authors:  Meng Zhang; Guanhua Hu; Nan Shao; Yunpeng Qin; Qian Chen; Yan Wang; Peng Zhou; Biao Cai
Journal:  Inflammopharmacology       Date:  2021-08-04       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.